Navigation Links
AAPS and PhRMA co-sponsor stability workshop

WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, and opportunities for networking and professional development. This workshop is co-sponsored with the Pharmaceutical Research and Manufacturers of America (PhRMA).

WHAT: In partnership with PhRMA, AAPS is pleased to present the workshop Current Trends in Stability Challenges with Today's New Products. This two-day event will address the complex role of stability evaluation in today's pharmaceutical development process and ongoing manufacturing environment, as well as some of the challenges scientists will face in all processes. The workshop will consist of talks by experts from the pharmaceutical industry, the World Health Organization and the U.S. Food and Drug Administration.

WHY: This workshop will bring together scientists and regulators from around the world to discuss current requirements, and best practices to address challenges in areas such as: stability by design and applications of new technologies to stability evaluation. Attendees will participate in four session tracks highlighting stability by design, stability strategies for drug device combinations and protein and biotech products, as well as regulatory harmonization of worldwide stability requirements.

September 24-25, 2009
Gaylord National Resort & Convention Center
National Harbor, MD

CONTACT: For additional information about the workshop, and to register, visit To set up an interview with a workshop speaker please contact Joe Catapano at 703-248-4772 or


Contact: Joseph Catapano
American Association of Pharmaceutical Scientists

Related biology news :

1. FDLI, PEN co-sponsor major conference on nanotechnology
2. Great Plains historical stability vulnerable to future changes
3. Predators and parasites may increase evolutionary stability
4. Human RecQ helicases, homologous recombination and genomic instability
5. Seeking sustainability in a world of instability
6. Breast cancer genome shows evolution, instability of cancer
7. Making a point: Picoscale stability in a room-temperature AFM
8. Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services
9. Temporary infidelity may contribute to the stability of ancient relationships
10. The downside of microtubule stability
11. Corn yield stability varies with rotations, fertility
Post Your Comments:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: